Takeda Pharmaceutical Co. Ltd. - Number of Consecutive Periods With Dividend Growth
Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Number-of-Consecutive-Periods-With-Dividend-Growth" stands at 8.00 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Number of Consecutive Periods With Dividend Growth" stands at 8.00. This represents an increase of 14.29 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 100.00 percent compared to the value the year prior.
The 1 year change in percent is 100.00.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +700.00%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.
Number of Consecutive Periods With Dividend Growth for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Number of Consecutive Periods With Dividend Growth | 905,699,262,464.00 |
 | Johnson & Johnson - Number of Consecutive Periods With Dividend Growth | 486,508,953,600.00 |
 | AbbVie Inc - Number of Consecutive Periods With Dividend Growth | 399,570,305,024.00 |
 | Roche Holding AG - Number of Consecutive Periods With Dividend Growth | 317,433,206,677.55 |
 | AstraZeneca PLC - Number of Consecutive Periods With Dividend Growth | 280,205,508,085.11 |